Andlauer Healthcare Group Inc. (TSE:AND) Director Ronald Martin Skelton Sells 10,000 Shares of Stock

Andlauer Healthcare Group Inc. (TSE:AND) Director Ronald Martin Skelton sold 10,000 shares of the stock in a transaction dated Friday, September 15th. The stock was sold at an average price of C$42.75, for a total transaction of C$427,455.00.

Andlauer Healthcare Group Trading Down 0.7 %

AND opened at C$42.93 on Tuesday. The company has a debt-to-equity ratio of 33.79, a current ratio of 2.60 and a quick ratio of 1.66. The company’s 50 day simple moving average is C$42.26 and its two-hundred day simple moving average is C$45.55. Andlauer Healthcare Group Inc. has a 1-year low of C$40.16 and a 1-year high of C$55.85. The firm has a market capitalization of C$862.03 million, a price-to-earnings ratio of 25.71 and a beta of 0.67.

Andlauer Healthcare Group (TSE:AND) last released its earnings results on Tuesday, August 1st. The company reported C$0.37 earnings per share for the quarter, missing analysts’ consensus estimates of C$0.44 by C($0.07). Andlauer Healthcare Group had a return on equity of 16.57% and a net margin of 10.89%. The business had revenue of C$157.36 million during the quarter, compared to analysts’ expectations of C$167.00 million. Analysts expect that Andlauer Healthcare Group Inc. will post 1.7604515 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Royal Bank of Canada decreased their price target on shares of Andlauer Healthcare Group from C$46.00 to C$45.00 and set a “sector perform” rating on the stock in a research note on Thursday, August 3rd. TD Securities decreased their price target on shares of Andlauer Healthcare Group from C$58.00 to C$56.00 and set a “buy” rating on the stock in a research note on Thursday, August 3rd. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, Andlauer Healthcare Group has an average rating of “Moderate Buy” and a consensus price target of C$53.96.

About Andlauer Healthcare Group

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.